EVERTOR 5MG Evertor 5mg belongs to the anti-neoplastic agent; it comes under mTOR kinase inhibitor (single transduction inhibitor). Evertor 5mg is an immunosuppressive macrolide. EVERTOR USED FOR Breast cancer The patient who failed to respond to the tablet letrozole or anastrozole therapy, would be treated with Evertor. Evertor 5mg is used in an advanced stage of breast cancer. Neuroendocrine tumors Evertor 5mg involved in the treatment of some neuroendocrine tumors like pancreatic, gastrointestinal or lung cancer. Renal cell cancer patient treating with Evertor 5mg after the failure of treatment with Sunitinib or Sorafenib. Evertor also used in the condition of: Heart, liver, kidney transplantation Waldenstrom macroglobulinemia Other carcinoid tumors MECHANISM OF ACTION Evertor is prohibitor of mammalian target of rapamycin (mTOR), a serine threonine kinase. Evertor bind with intercellular protein (FKBP-12), leads to inhibitory complex formation wi...